[Metabolism of adenosine, AMP and ATP in rats].
Metabolism of [14C]adenosine in a dose of 100 mg per 1 kg of mass and [14C]ATP in the equimolar quantity was studied in rats after intraperitoneal administration. Adenosine is shown to enter tissues of the liver, spleen, thymus, heart and erythrocytes where it phosphorylates into adenine nucleotides (mainly ATP) and deaminates into inosine. The content of adenosine increases for a short period in the above tissues, except for erythrocytes and plasma. The latter accumulates a considerable amount of inosine and hypoxanthine, but only traces of uric acid, xanthine and adenine nucleotides. ATP administered to rats catabolizes through the adenosine formation. The exogenic adenosine and ATP replace in tissues and erythrocytes only a slight part (1-12%) of their total adenine nucleotide pool. The content of these metabolites and ADP in the blood plasma does not change essentially under the effect of adenosine, ATP and AMP. It is shown on rats whose adenine nucleotide pool of cells is marked by the previous administration of [14C]adenine that injections of adenosine, ATP and inosine do not accelerate catabolism of adenine nucleotides in tissues and erythrocytes as well as do not increase the level of catabolism products in the blood plasma. Adenosine enhances and ATP lowers the content of cAMP in spleen and myocardium, respectively.
Dmitrenko
N P
NP
Goroshnikova
T V
TV
D000241:Adenosine / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000097:blood / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism; D008213:Lymphocyte Activation; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution
D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D000241:Adenosine
Metabolizm adenozina, AMP i ATP u krys.